Vnitr Lek 2020, 66(6):360-362 | DOI: 10.36290/vnl.2020.102

Influenza and its complications

Adam Vitouš, František Stejskal
Infekční oddělení, Krajská nemocnice Liberec, a. s.
Technická univerzita Liberec
Klinika infekčních nemocí, 2. LF UK a Nemocnice Na Bulovce, Praha
Ústav imunologie a mikrobiologie, 1. LF UK a VFN, Praha

Influenza is viral acute respiratory illness. During winter season flu occurs in local epidemics of various magnitude. Influenza causes substantial loss of workdays, human suffering, and significant mortality rate in population, despite the existing treatment and effective vaccination.

Keywords: flu, influenza, infection, vaccine, complications.

Published: October 8, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vitouš A, Stejskal F. Influenza and its complications. Vnitr Lek. 2020;66(6):360-362. doi: 10.36290/vnl.2020.102.
Download citation

References

  1. Drake JW. Rates of spontaneous mutation among RNA viruses. Proc Natl Acad Sci, USA 1993. 90(9): 4171-4175. Go to original source... Go to PubMed...
  2. Kilbourne ED. Influenza pandemics of 20th century. Emerg Infect, DiS. 2006 Jan. 12(1): 9-14. Go to original source... Go to PubMed...
  3. Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (NCIRD), www.cdc.gov/flu/about/disease/spread.htm
  4. Bridges CB, Kuehnert MJ, Hall CB. Transmission of influenza: implications for control in health care settings. Clin Infect, DiS. 2003; 37: 1094-1101 10.1086/378292. Go to original source... Go to PubMed...
  5. Avian influenza: fact sheet. World Health Organization. www.who.int/mediacentre/factsheet/avian_influenza/en/print.html
  6. Tasher D, Stein M, Simoea EA, et al. Invasive bacterial infections in relation to influenza outbreaks, 2006-2010. Clin Inf, DiS. 2011 Dec. 53(12): 1199-207. Go to original source... Go to PubMed...
  7. Won Suk Choi, Ji Hyeon Baek, Yu Bin Seo, et al. Severe influenza treatment guidelines. Transgovernmental Enterprise for Pandemic Influenza in Korea Korean J Intern Med 2014; 29: 132-147. 2014 pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org. Go to original source... Go to PubMed...
  8. Kotey E, Lukosaityte D, et al. Current and Novel Approaches in Influenza Management. Vaccines (Basel). 2019 Jun; 7(2): 53. Go to original source... Go to PubMed...
  9. Kwong JC, Schwartz KL, Cempitelli MA, et al. Acute Myocardial Infarction after Laboratory‑confirmed Influenza Infection. N Engl J Med 2018, 378: 345. Go to original source... Go to PubMed...
  10. Waren‑Gash C, Bhaskaran K, Hayward A, et al. Circulating influenza virus, climatic factors and acute myocardial infarction: a time series study in England and Wales and Hong Kong. J Infect Dis 2011. 203: 1710. Go to original source... Go to PubMed...
  11. Naghavi M, Barlas Z, Siadaty S, et al. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 2000;102:3039-45. Go to original source... Go to PubMed...
  12. Puig‑Barbera J, Diez‑Domingo J, Varea A, et al. Effectiveness of MF59-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly. Vaccine 2007; 25: 7313-7321. Go to original source... Go to PubMed...
  13. Siriwardena AN, Gwini SM, Coupland CA. Influenza vaccination, pneumococcal vaccination and risk of acute myocardial infarction: matched case‑control study. CMAJ 2010; 182: 1617-1623. Go to original source... Go to PubMed...
  14. Warren‑Gash C, Blackburn R, et al. Laboratory‑confirmed respiratory infections as triggers for acute myocardial infarction and stroke: a self‑controlled case series analysis of national linked datasets from Scotland. European Respiratory Journal 2018 51: 1701794. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.